Roche To Pay Chiron $78M To Settle Patent Dispute

Law360, New York (September 12, 2004, 12:00 AM EDT) -- Swiss drug maker F. Hoffmann-La Roche will pay U.S. biotech company Chiron Corp. $78 million to settle a dispute over licensing fees and royalties related to nucleic acid testing methods for HIV.

Under the terms of the settlement agreement, Chiron will receive the lump-sum payment in lieu of royalties after Jan. 1, 2005, and will retain all funds paid to it by Roche while the matter was in dispute, the companies said.

Roche may elect to obtain a partial refund of those payments and revert to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.